Speaker
President & Chief Medical Officer, Palisade Bio
Mitchell Jones, President & Chief Medical Officer at Palisade Bio, is speaking at 10th Antifibrotic Drug Development Summit 2026 (Boston, United States of America, 1–3 Dec 2026) in the session “Advancing PDE4 Inhibition Beyond IBD: Implications for PDE4 Inhibition & Pleiotropic Mechanisms in Systemic Sclerosis”.
1–3 Dec 2026Boston, United States of America
Director, Madrigal Pharmaceuticals
Executive Director & Head of Liver Disease Research & Drug Discovery, GI-Ddu, Takeda Pharmaceutical
Principal Scientist II, Novartis AG
CMO, Mediar Therapeutics
Co-Founder & Chief Executive Officer, Refoxy Pharmaceuticals
Head of Translational Sciences, Fibrocor Therapeutics
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Mitchell Jones, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].